0001209191-17-021699.txt : 20170320
0001209191-17-021699.hdr.sgml : 20170320
20170320161049
ACCESSION NUMBER: 0001209191-17-021699
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170316
FILED AS OF DATE: 20170320
DATE AS OF CHANGE: 20170320
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FRIEDMAN PAUL A
CENTRAL INDEX KEY: 0001236927
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 17701520
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION
STREET 2: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-16
0
0000879169
INCYTE CORP
INCY
0001236927
FRIEDMAN PAUL A
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
1
0
0
0
Common Stock
2017-03-16
4
M
0
5458
18.32
A
302976
D
Common Stock
2017-03-16
4
M
0
2849
18.32
A
305825
D
Common Stock
2017-03-16
4
S
0
8307
151.45
D
297518
D
Common Stock
2017-03-17
4
M
0
41693
18.32
A
339211
D
Common Stock
2017-03-17
4
S
0
41693
148.18
D
297518
D
Non-Qualified Stock Option (right to buy)
18.32
2017-03-16
4
M
0
5458
0.00
D
2020-02-08
Common Stock
5458
0
D
Non-Qualified Stock Option (right to buy)
18.32
2017-03-16
4
M
0
2849
0.00
D
2020-02-08
Common Stock
2849
141693
D
Non-Qualified Stock Option (right to buy)
18.32
2017-03-17
4
M
0
41693
0.00
D
2020-02-08
Common Stock
41693
100000
D
Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
Represents weighted average sale price. Actual sale prices ranged from $151.09 - $151.75.
Represents weighted average sale price. Actual sale prices ranged from $148.00 - $148.92.
Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
/s/ Paul A. Friedman
2017-03-20